0001140361-12-034167.txt : 20120727 0001140361-12-034167.hdr.sgml : 20120727 20120727140654 ACCESSION NUMBER: 0001140361-12-034167 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120725 FILED AS OF DATE: 20120727 DATE AS OF CHANGE: 20120727 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AYERS JONATHAN W CENTRAL INDEX KEY: 0001184149 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 12989991 MAIL ADDRESS: STREET 1: IDEXX LABORATORIES, INC. STREET 2: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 4 1 doc1.xml FORM 4 X0306 4 2012-07-25 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001184149 AYERS JONATHAN W ONE IDEXX DRIVE WESTBROOK ME 04092 1 1 0 0 Chairman, President & CEO Common Stock 2012-07-25 4 M 0 20000 0 A 351686 D Common Stock 2012-07-25 4 S 0 7900 87.0524 D 343786 D Common Stock 2012-07-25 4 S 0 7100 87.5389 D 336686 D Non-Qualified Stock Option (right to buy) 17.1350 2012-07-25 4 M 0 20000 0 D 2013-02-06 Common Stock 20000 124164 D Includes 79 shares and 71 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 03/30/2012 and 06/30/2012, respectively. The sale reported above was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 04/27/2012. The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $86.42 to $87.41, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 and 4 to this Form 4. The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $87.43 to $88.045, inclusive. Grant of options to buy shares of common stock becomes exercisable as to 30,000 shares on 02/06/2004, 02/06/2005, 02/06/2006, 02/06/2007, and the remaining 24,164 shares on 02/06/2008. Conan R. Deady, Attorney-in-fact for Jonathan W. Ayers 2012-07-27